|
|
Post by kc on Jan 17, 2018 15:45:33 GMT -5
I like this guy's #4 Pick...
At least one of these biotech stocks should appeal to every investor
By Aaron Levitt, InvestorPlace Contributor
investorplace.com/2018/01/5-big-biotech-stocks-buy-2018/#.Wl-1sSzrt9B
Looking for the archetype “lotto” ticket biotech stock? Then MannKind Corporation (NASDAQ:MKND) is it.
MannKind has just one product — Afrezza. The drug is an inhalable insulin used to treat diabetes. It could be a miracle cure for those suffering from the disease. Things haven’t turned out well for MKND over the years, however.
Prescriptions for the drug continue to come in well under expectations, and revenues from these written prescriptions have been paltry at best. That’s a problem when you are running low on cash and have some pretty decent debts on your balance sheet.
But there have been some positives lately — like a label ruling update from the FDA and the potential for Afrezza to be covered by insurance for some patients. The hope is that these positives, as well as higher scripts, will happen before MannKind runs out of cash. If and when that does, MKND should pop much higher.
At $2.50 per share, MKND stock is really a lotto ticket. But it may be worth it for investors looking for to add some risk to their portfolios.
|
|
|
|
Post by kite on Jan 17, 2018 15:48:15 GMT -5
Very nice find! MNKD is the cheapest of them all... Everyone else is in the triple digits... one day!
Im curious to know how he came about this list
|
|
|
|
Post by kc on Jan 17, 2018 15:59:17 GMT -5
|
|
|
|
Post by barnstormer on Jan 17, 2018 17:42:43 GMT -5
It's hard to get thrilled about comparing my shares to a "lotto ticket" (eg AAron Levitt. I buy lots of lotto tickets. Why not somebody has to win and you can't win if you don't play. It's cheap fun. Owning MNKD is a lot more stressful. All of us longs believe in Afrezza and TS. Today was the first day that seems to show that the tide may be turning for the SP. Staying green after watching big block trades is encouraging. Now we need Mike to give us a reason to run. Release the Kraken aka the STAT study and our shares/lotto tickets will pay off bigly!
|
|
|
|
Post by kc on Jan 17, 2018 17:57:03 GMT -5
|
|
|
|
Post by dreamboatcruise on Jan 20, 2018 18:40:12 GMT -5
It's hard to get thrilled about comparing my shares to a "lotto ticket" (eg AAron Levitt. I buy lots of lotto tickets. Why not somebody has to win and you can't win if you don't play. It's cheap fun. Owning MNKD is a lot more stressful. All of us longs believe in Afrezza and TS. Today was the first day that seems to show that the tide may be turning for the SP. Staying green after watching big block trades is encouraging. Now we need Mike to give us a reason to run. Release the Kraken aka the STAT study and our shares/lotto tickets will pay off bigly! My theory about lotto tickets is that if I'm really lucky enough to win I should be lucky enough to find the ticket on the sidewalk after someone accidentally dropped it. My approach simply changes the odds of a jackpot from impossibly implausible to impossibly implausible squared.  |
|
|
|
Post by brentie on Jan 21, 2018 9:12:20 GMT -5
|
|
|
|
Post by boca1girl on Jan 21, 2018 10:03:27 GMT -5
I was surprised to see a somewhat positive article on MNKD from the Fool. I own SENS also. They are awaiting European approval for a 180 day sensor. I don’t know when they anticipate FDA approval. |
|
|
|
Post by thekindaguyiyam on Jan 22, 2018 13:41:49 GMT -5
It's hard to get thrilled about comparing my shares to a "lotto ticket" (eg AAron Levitt. I buy lots of lotto tickets. Why not somebody has to win and you can't win if you don't play. It's cheap fun. Owning MNKD is a lot more stressful. All of us longs believe in Afrezza and TS. Today was the first day that seems to show that the tide may be turning for the SP. Staying green after watching big block trades is encouraging. Now we need Mike to give us a reason to run. Release the Kraken aka the STAT study and our shares/lotto tickets will pay off bigly! My theory about lotto tickets is that if I'm really lucky enough to win I should be lucky enough to find the ticket on the sidewalk after someone accidentally dropped it. My approach simply changes the odds of a jackpot from impossibly implausible to impossibly implausible squared. You sound like Rodney Dangerfield "I get no respect. The way my luck is running, if I was a politician I would be honest" |
|
|
|
Post by dreamboatcruise on Jan 22, 2018 13:42:23 GMT -5
I was surprised to see a somewhat positive article on MNKD from the Fool. I own SENS also. They are awaiting European approval for a 180 day sensor. I don’t know when they anticipate FDA approval. Is it accurate enough to get FDA approval for being the primary BG measurement for dosing? That's impressive that they have a sensor that lasts 180 days. Does one need to go to doctor's office to have the old sensor removed and new one inserted? |
|
|
|
Post by boca1girl on Jan 22, 2018 14:53:10 GMT -5
I was surprised to see a somewhat positive article on MNKD from the Fool. I own SENS also. They are awaiting European approval for a 180 day sensor. I don’t know when they anticipate FDA approval. Is it accurate enough to get FDA approval for being the primary BG measurement for dosing? That's impressive that they have a sensor that lasts 180 days. Does one need to go to doctor's office to have the old sensor removed and new one inserted? It is only approved outside of the US right now (Europe only?). They have an approved 90 days sensor and are awaiting approval on a 180 day sensor. Yes, medical person needs to remove and replace sensor. That’s a big drawback as I see it. |
|
|
|
Post by boca1girl on Feb 26, 2018 8:48:28 GMT -5
Is it accurate enough to get FDA approval for being the primary BG measurement for dosing? That's impressive that they have a sensor that lasts 180 days. Does one need to go to doctor's office to have the old sensor removed and new one inserted? It is only approved outside of the US right now (Europe only?). They have an approved 90 days sensor and are awaiting approval on a 180 day sensor. Yes, medical person needs to remove and replace sensor. That’s a big drawback as I see it. Update on SENS: mobilemarketingmagazine.com/sony-ericsson-altair-senseonics-diabetes-monitoring-wristbandSony and Ericsson have teamed up with LTE chipset provider Altair Semiconductor to develop a concept for a wearable that helps diabetics monitor their glucose levels. The wristband monitors and displays blood sugar levels, activity, sleep, heart rate, and alerts the user when their glucose levels drop. It has been designed to work with the Sony cloud solution and Xperia smart app. The prototype connects to a Continuous Glucose Monitoring (CGM) smart transmitter – provided by Senseonics – via Bluetooth, and is powered by Altair’s ALT1210 LTE-M/Cat-M1 chipset. “The wristband prototype is one proof of concept for health services with the potential to significantly improve quality of life,” said Izumi Kawanishi, director and executive vice president of the product business group at Sony Mobile Communications. “We selected Altair's ALT1210 chipset as it offers unparalleled low power consumption and cost efficiency, while its reduced size is essential for integration in the wristband form factor.” No images of the concept have been released, but Ericsson will demonstrate the wristband at its booth at Mobile World Congress (MWC) from 26 February to 1 March in Barcelona, Spain. |
|
/production/original_573352236.gif)
